Search - tctmd.com

Displaying 261 - 280 of 390

Sort: Relevancy | Date

Presentation TCT 2014

TCT 688: One-Year Results of Transcatheter Aortic Valve Therapy for Failed Surgical Bioprostheses PARTNER II Valve-in-Valve Registry

Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith, Rakesh M. Suri

September 13, 2014

Presentation TCT 2014

TCT 688: One-Year Results of Transcatheter Aortic Valve Therapy for Failed Surgical Bioprostheses PARTNER II Valve-in-Valve Registry

Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith, Rakesh M. Suri

September 13, 2014

Presentation TCT 2014

Lessons from the TVT Registry

Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith, John D. Carroll

September 13, 2014

Presentation TCT 2014

Lessons from the ADVANCE Registry

Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith, Axel Linke

September 13, 2014

Presentation TCT 2014

Lessons from the CoreValve US Trials

Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith, Jeffrey J. Popma

September 13, 2014

Presentation TCT 2014

Lessons from the PARTNER Trials

Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith

September 13, 2014

Presentation TCT 2014

Updates from SURTAVI in Intermediate-Risk Patients

Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Patrick W. Serruys

September 13, 2014

Presentation TCT 2014

NIRS for Identifying Vulnerable Plaque Prior to Coronary Thrombosis

Presenter: Gary S. Mintz, Patrick W. Serruys, Ryan D. Madder, Akiko Maehara

September 13, 2014

Presentation TCT 2014

OCT for Identifying Vulnerable Plaque Prior to Coronary Thrombosis

Presenter: Gary S. Mintz, Patrick W. Serruys, Ryan D. Madder, Yuji Ikari

September 13, 2014

Presentation TCT 2014

NIRS Utility in the Unstable Patient With ACS/NSTEMI

Presenter: Gary S. Mintz, Patrick W. Serruys, Ryan D. Madder, David Erlinge

September 13, 2014

Presentation TCT 2014

OCT Utility in the Unstable Patient With ACS/NSTEMI

Presenter: Gary S. Mintz, Patrick W. Serruys, Ryan D. Madder, Francesco Prati

September 13, 2014

Presentation TCT 2014

PERFECT-LUTS: Evaluation of Endovascular Pelvic Arterial Revascularization in Patients with Lower Urinary Tract Symptoms and Erectile Dysfunction

Presenter: Patrick W. Serruys, Tzung-Dau Wang

September 13, 2014

Presentation TCT 2014

CONTRAST: A Prospective, Randomized Trial of N-Acetylcysteine Versus Sodium Bicarbonate Versus N-Acetylcysteine Plus Sodium Bicarbonate in Patients at Risk for Contrast Nephropathy

Presenter: Patrick W. Serruys, Huay Cheem Tan

September 13, 2014

Presentation TCT 2014

CANARY: Evaluation of the Relationship Between Intravascular Ultrasound and Near Infrared Spectroscopy Lipid Parameters with Periprocedural Myonecrosis, with an Integrated Randomized Trial of Distal Protection to Prevent PCI-Related Myocardial Infarction

Presenter: Patrick W. Serruys, Gregg W. Stone

September 13, 2014

Presentation TCT 2014

EUROMAX STR: ST-Segment Resolution Analysis in Patients with ST-Segment Elevation Myocardial Infarction Randomized to Prehospital Bivalirudin Versus Heparin Plus a Routine Glycoprotein IIb/IIIa Inhibitor Prior to Primary Percutaneous Coronary Intervention

Presenter: Patrick W. Serruys, Jurrien M. Ten Berg

September 13, 2014

Presentation TCT 2014

HORIZONS-AMI and EUROMAX Stent Thrombosis: Predictors of Stent Thrombosis and Risk for 30-Day Mortality After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Presenter: Patrick W. Serruys, George D. Dangas

September 13, 2014

$SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups$

Presentation TCT 2014

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

Presenter: Patrick W. Serruys, Deepak L. Bhatt

September 13, 2014

Presentation TCT 2014

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke

September 13, 2014

Presentation TCT 2014

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds

September 13, 2014

Presentation TCT 2014

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia

September 13, 2014

Advertisement

TCT 688: One-Year Results of Transcatheter Aortic Valve Therapy for Failed Surgical Bioprostheses PARTNER II Valve-in-Valve Registry

TCT 688: One-Year Results of Transcatheter Aortic Valve Therapy for Failed Surgical Bioprostheses PARTNER II Valve-in-Valve Registry

Lessons from the TVT Registry

Lessons from the ADVANCE Registry

Lessons from the CoreValve US Trials

Lessons from the PARTNER Trials

Updates from SURTAVI in Intermediate-Risk Patients

NIRS for Identifying Vulnerable Plaque Prior to Coronary Thrombosis

OCT for Identifying Vulnerable Plaque Prior to Coronary Thrombosis

NIRS Utility in the Unstable Patient With ACS/NSTEMI

OCT Utility in the Unstable Patient With ACS/NSTEMI

PERFECT-LUTS: Evaluation of Endovascular Pelvic Arterial Revascularization in Patients with Lower Urinary Tract Symptoms and Erectile Dysfunction

CONTRAST: A Prospective, Randomized Trial of N-Acetylcysteine Versus Sodium Bicarbonate Versus N-Acetylcysteine Plus Sodium Bicarbonate in Patients at Risk for Contrast Nephropathy

CANARY: Evaluation of the Relationship Between Intravascular Ultrasound and Near Infrared Spectroscopy Lipid Parameters with Periprocedural Myonecrosis, with an Integrated Randomized Trial of Distal Protection to Prevent PCI-Related Myocardial Infarction

EUROMAX STR: ST-Segment Resolution Analysis in Patients with ST-Segment Elevation Myocardial Infarction Randomized to Prehospital Bivalirudin Versus Heparin Plus a Routine Glycoprotein IIb/IIIa Inhibitor Prior to Primary Percutaneous Coronary Intervention

HORIZONS-AMI and EUROMAX Stent Thrombosis: Predictors of Stent Thrombosis and Risk for 30-Day Mortality After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content